154 related articles for article (PubMed ID: 25491537)
1. Efficacy and safety of Flos Abelmoschus manihot (Malvaceae) on type 2 diabetic nephropathy: A systematic review.
Chen YZ; Gong ZX; Cai GY; Gao Q; Chen XM; Tang L; Wei RB; Zhou JH
Chin J Integr Med; 2015 Jun; 21(6):464-72. PubMed ID: 25491537
[TBL] [Abstract][Full Text] [Related]
2. Treatment of chronic kidney disease using a traditional Chinese medicine, Flos Abelmoschus manihot (Linnaeus) Medicus (Malvaceae).
Chen Y; Cai G; Sun X; Chen X
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):145-8. PubMed ID: 26667396
[TBL] [Abstract][Full Text] [Related]
3. Chemical constituents, clinical efficacy and molecular mechanisms of the ethanol extract of Abelmoschus manihot flowers in treatment of kidney diseases.
Li N; Tang H; Wu L; Ge H; Wang Y; Yu H; Zhang X; Ma J; Gu HF
Phytother Res; 2021 Jan; 35(1):198-206. PubMed ID: 32716080
[TBL] [Abstract][Full Text] [Related]
4. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
5.
Shi L; Feng L; Zhang M; Li X; Yang Y; Zhang Y; Ni Q
Evid Based Complement Alternat Med; 2019; 2019():9679234. PubMed ID: 31118973
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of Huangkui capsule for diabetic nephropathy: A protocol for systematic review and meta-analysis.
An W; Huang Y; Chen S; Teng T; Liu J; Xu Y
Medicine (Baltimore); 2021 Oct; 100(42):e27569. PubMed ID: 34678897
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy.
Zhou L; An XF; Teng SC; Liu JS; Shang WB; Zhang AH; Yuan YG; Yu JY
J Med Food; 2012 May; 15(5):461-8. PubMed ID: 22439874
[TBL] [Abstract][Full Text] [Related]
8. Effect of Huangshukuihua (Flos Abelmoschi Manihot) on diabetic nephropathy: a meta-analysis.
Yang G; Zhang M; Zhang M; Chen S; Chen P
J Tradit Chin Med; 2015 Feb; 35(1):15-20. PubMed ID: 25842723
[TBL] [Abstract][Full Text] [Related]
9. Effects of total flavones of Abelmoschus manihot (L.) on the treatment of diabetic nephropathy via the activation of solute carriers in renal tubular epithelial cells.
Yu H; Tang H; Wang M; Xu Q; Yu J; Ge H; Qiang L; Tang W; Gu HF
Biomed Pharmacother; 2023 Dec; 169():115899. PubMed ID: 37984306
[TBL] [Abstract][Full Text] [Related]
10. Supplementation of
Kim H; Dusabimana T; Kim SR; Je J; Jeong K; Kang MC; Cho KM; Kim HJ; Park SW
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30405076
[TBL] [Abstract][Full Text] [Related]
11. Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.
Li P; Chen YZ; Lin HL; Ni ZH; Zhan YL; Wang R; Yang HT; Fang JA; Wang NS; Li WG; Sun XF; Chen XM
Trials; 2017 Apr; 18(1):170. PubMed ID: 28395659
[TBL] [Abstract][Full Text] [Related]
12. Total flavones of Abelmoschus manihot improve diabetic nephropathy by inhibiting the iRhom2/TACE signalling pathway activity in rats.
Liu S; Ye L; Tao J; Ge C; Huang L; Yu J
Pharm Biol; 2017 Dec; 56(1):1-11. PubMed ID: 29221422
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a cytotoxic polysaccharide from the flower of Abelmoschus manihot.
Zheng X; Liu Z; Li S; Wang L; Lv J; Li J; Ma X; Fan L; Qian F
Int J Biol Macromol; 2016 Jan; 82():284-90. PubMed ID: 26478094
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profiles of the Flos Abelmoschus manihot extract by intestinal bacteria from the normal and CKD model rats based on UPLC-Q-TOF/MS.
Du LY; Tao JH; Jiang S; Qian DW; Guo JM; Duan JA
Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27451133
[TBL] [Abstract][Full Text] [Related]
15. The therapeutic effect and possible harm of puerarin for treatment of stage III diabetic nephropathy: a meta-analysis.
Wang B; Chen S; Yan X; Li M; Li D; Lv P; Ti G
Altern Ther Health Med; 2015; 21(1):36-44. PubMed ID: 25599431
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Abelmoschus manihot capsule combined with ACEI/ARB on diabetic kidney disease: a systematic review and meta analysis.
Tan Y; Zhang Z; Zhou P; Zhang Q; Li N; Yan Q; Huang L; Yu J
Front Pharmacol; 2023; 14():1288159. PubMed ID: 38249351
[No Abstract] [Full Text] [Related]
17. Flos Abelmoschus manihot extract attenuates DSS-induced colitis by regulating gut microbiota and Th17/Treg balance.
Zhang W; Cheng C; Han Q; Chen Y; Guo J; Wu Q; Zhu B; Shan J; Shi L
Biomed Pharmacother; 2019 Sep; 117():109162. PubMed ID: 31254739
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial.
Zhang L; Li P; Xing CY; Zhao JY; He YN; Wang JQ; Wu XF; Liu ZS; Zhang AP; Lin HL; Ding XQ; Yin AP; Yuan FH; Fu P; Hao L; Miao LN; Xie RJ; Wang R; Zhou CH; Guan GJ; Hu Z; Lin S; Chang M; Zhang M; He LQ; Mei CL; Wang L; Chen X
Am J Kidney Dis; 2014 Jul; 64(1):57-65. PubMed ID: 24631042
[TBL] [Abstract][Full Text] [Related]
19. [Absorption of flavonoids from Abelmoschus manihot extract by in situ intestinal perfusion].
Xue CF; Guo JM; Qian DW; Duan JA; Shu Y
Yao Xue Xue Bao; 2011 Apr; 46(4):454-9. PubMed ID: 21751500
[TBL] [Abstract][Full Text] [Related]
20. Conjugated metabolites represent the major circulating forms of Abelmoschus manihot in vivo and show an altered pharmacokinetic profile in renal pathology.
Guo J; Du L; Shang E; Li T; Liu Y; Qian D; Tang Y; Duan J
Pharm Biol; 2016; 54(4):595-603. PubMed ID: 26186460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
